Johnson & JohnsonJNJ
$255.49-3.83%-10.1800Spread: 2.69
Pharmaceuticals · MCap: $618.33B
MA:||
Open
$259.45
High
$260.35
Low
$254.65
Prev Close
$265.67
Volume
345,987
SMA 20
$240.81
SMA 50
$223.82
RSI (14)
64.8
ATR (14)
$3.71
Avg Vol (20d)
287,654
Prior Close
$243.43
H: $245.26 L: 242.06
Bollinger Bands
U $252.27M $240.81L $229.35
MACD
Line 6.6137Signal 7.1522Hist -0.5384
Recent News
Johnson & Johnson Advances Cancer and Immunology Treatments With Major Biotech Deals
benzinga · 7/30/2026
Johnson & Johnson Puts 15-Year Meritless Talc Litigation To Rest
benzinga · 7/28/2026
Stock Market Today: Dow Jones Futures Gain as Coca-Cola Jumps After Q2 Beat, S&P 500, Nasdaq 100 Decline—Boeing, Johnson & Johnson in Focus (UPDATED)
benzinga · 7/28/2026
FDA Approves Johnson & Johnson Table-Integrated OTTAVA Robotic Surgery System
benzinga · 7/22/2026
Trump Sets August 1 Start for Generic Drug Tariff Clock, Warns of 200% Duties: Companies Must 'Build Plant and Equipment' in US
benzinga · 7/22/2026
UnitedHealth Rally Sparks Bullish Case for Healthcare ETFs Despite Medicare Advantage Losses
benzinga · 7/16/2026
Johnson & Johnson Posts Upbeat Q2: IM Momentum Building Into 2027, Says Bullish Analyst
benzinga · 7/16/2026
New Jersey Rep. Thomas Kean Sold Over $26K Worth of Alphabet Stock: Here’s What You Should Know
benzinga · 7/16/2026
Full Transcript: Johnson & Johnson Q2 2026 Earnings Call
benzinga · 7/16/2026
Johnson & Johnson Finds Growth Beyond Legacy Drugs, Lifts 2026 Outlook
benzinga · 7/15/2026